Preemie heart clue: chemical levels may predict ductus risk
NCT ID NCT07338370
First seen Jan 17, 2026 · Last updated May 14, 2026 · Updated 19 times
Summary
This study looks at whether levels of a natural chemical called PGE2 in very premature babies (born at 32 weeks or earlier) can predict if they will develop a serious heart condition called patent ductus arteriosus (PDA). Researchers will measure PGE2 in the blood and compare it to heart ultrasound results. No treatments are given; the goal is simply to learn more about how this condition develops.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATENT DUCTUS ARTERIOSUS IN PRETERM INFANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Faculty of Medicine, Ain Shams, University
RECRUITINGCairo, Abbasia, 11517, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.